We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why You Should Retain Ingevity (NGVT) Stock in Your Portfolio
Read MoreHide Full Article
Ingevity Corporation (NGVT - Free Report) is expected to benefit from the acquisition of the Capa caprolactone business and growth in its applications driven by regulations and technology adoption amid a weak demand environment.
Shares of this specialty chemicals and materials maker are down 39.8% year to date, compared with the 26.3% rise of its industry.
Let’s find out why this Zacks Rank #3 (Hold) stock is worth retaining at the moment.
What’s Woking in NGVT’s Favor?
Ingevity is benefiting from the acquisition of the Capa caprolactone business. Capa has a strong and market-leading business that focuses on high-growth end-use applications. The buyout enabled Ingevity with a new technology platform to drive revenue and earnings growth. The addition of the engineered polymers product line through the acquisition is driving the company’s Performance Chemicals division. The acquired business is expected to deliver strong growth in 2020.
Ingevity is also witnessing strong momentum in its Performance Materials division as reflected by an 11% increase in sales in the last reported quarter. It is benefiting from strong demand for base automotive activated carbon products and honeycomb scrubber products, as a result of automotive customers’ complete implementation of the U.S. and Canada emission standards.
The company is also gaining from higher sales in China as automakers in the country have essentially completed the implementation of the China 6 standard.
Moreover, Ingevity is seeing robust growth in pavement technologies on strength in North America. The company is also witnessing improvement in certain countries in South America. It is seeing strong adoption of Evotherm warm-mix technology.
A Few Concerns
Ingevity is exposed to weakness in industrial applications. In the last reported quarter, its Performance Chemicals unit was affected by a slowdown in industrial activities. The company witnessed a roughly 17% decline in sales related to industrial specialties applications in the quarter, hurt by weakness in industrial demand and the exit of an unprofitable distribution deal. Pressure in industrial specialties is likely to continue moving ahead.
The company also sees sustained weakness in the rosin market in 2020. Further, Ingevity expects the oilfield industry to be volatile throughout 2020, with a significant impact on drilling in North America.
Moreover, the company anticipates a year-over-year revenue decline of 25-30% for the second quarter. Also, it expects a year-over-year decline in adjusted EBITDA of 35-40% for the quarter. The outlook is partly driven by the closure of auto production in North America and Europe.
The company recently said that it is taking certain cost-reduction measures to realign its cost structure in response to lower demand for some of its products due to the coronavirus outbreak.
Ingevity stated that it will streamline manufacturing processes, and lower spending on services and consultants. Moreover, it noted that it will lower some benefits for salaried employees as well as reduce and restructure headcount through an early retirement program, and other job cuts. The company expects to record pre-tax charges in second-quarter 2020 as part of the restructuring.
Harmony Gold has an expected earnings growth rate of 28.6% for the current year. The company’s shares have shot up 87% in the past year. It presently carries a Zacks Rank #2.
AngloGold has a projected earnings growth rate of 109.9% for the current year. The company’s shares have surged around 67% in a year. It currently has a Zacks Rank #2.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
Image: Bigstock
Why You Should Retain Ingevity (NGVT) Stock in Your Portfolio
Ingevity Corporation (NGVT - Free Report) is expected to benefit from the acquisition of the Capa caprolactone business and growth in its applications driven by regulations and technology adoption amid a weak demand environment.
Shares of this specialty chemicals and materials maker are down 39.8% year to date, compared with the 26.3% rise of its industry.
Let’s find out why this Zacks Rank #3 (Hold) stock is worth retaining at the moment.
What’s Woking in NGVT’s Favor?
Ingevity is benefiting from the acquisition of the Capa caprolactone business. Capa has a strong and market-leading business that focuses on high-growth end-use applications. The buyout enabled Ingevity with a new technology platform to drive revenue and earnings growth. The addition of the engineered polymers product line through the acquisition is driving the company’s Performance Chemicals division. The acquired business is expected to deliver strong growth in 2020.
Ingevity is also witnessing strong momentum in its Performance Materials division as reflected by an 11% increase in sales in the last reported quarter. It is benefiting from strong demand for base automotive activated carbon products and honeycomb scrubber products, as a result of automotive customers’ complete implementation of the U.S. and Canada emission standards.
The company is also gaining from higher sales in China as automakers in the country have essentially completed the implementation of the China 6 standard.
Moreover, Ingevity is seeing robust growth in pavement technologies on strength in North America. The company is also witnessing improvement in certain countries in South America. It is seeing strong adoption of Evotherm warm-mix technology.
A Few Concerns
Ingevity is exposed to weakness in industrial applications. In the last reported quarter, its Performance Chemicals unit was affected by a slowdown in industrial activities. The company witnessed a roughly 17% decline in sales related to industrial specialties applications in the quarter, hurt by weakness in industrial demand and the exit of an unprofitable distribution deal. Pressure in industrial specialties is likely to continue moving ahead.
The company also sees sustained weakness in the rosin market in 2020. Further, Ingevity expects the oilfield industry to be volatile throughout 2020, with a significant impact on drilling in North America.
Moreover, the company anticipates a year-over-year revenue decline of 25-30% for the second quarter. Also, it expects a year-over-year decline in adjusted EBITDA of 35-40% for the quarter. The outlook is partly driven by the closure of auto production in North America and Europe.
The company recently said that it is taking certain cost-reduction measures to realign its cost structure in response to lower demand for some of its products due to the coronavirus outbreak.
Ingevity stated that it will streamline manufacturing processes, and lower spending on services and consultants. Moreover, it noted that it will lower some benefits for salaried employees as well as reduce and restructure headcount through an early retirement program, and other job cuts. The company expects to record pre-tax charges in second-quarter 2020 as part of the restructuring.
Ingevity Corporation Price and Consensus
Ingevity Corporation price-consensus-chart | Ingevity Corporation Quote
Stocks to Consider
Better-ranked stocks in the basic materials space include Agnico Eagle Mines Limited (AEM - Free Report) , Harmony Gold Mining Company Limited (HMY - Free Report) and AngloGold Ashanti Limited (AU - Free Report) .
Agnico Eagle has a projected earnings growth rate of 53.6% for the current year. The company’s shares have rallied roughly 25% in a year. It currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Harmony Gold has an expected earnings growth rate of 28.6% for the current year. The company’s shares have shot up 87% in the past year. It presently carries a Zacks Rank #2.
AngloGold has a projected earnings growth rate of 109.9% for the current year. The company’s shares have surged around 67% in a year. It currently has a Zacks Rank #2.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>